News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Canada imposes a temporary 10% safeguard tariff on imported canned vegetables.
  • The tariff will remain in force for up to 200 days while officials reassess market conditions.
  • The Department of Finance said the move follows an investigation into trade diversion.
  • Policy aims to protect domestic agricultural producers and food processors from import competition.
  • Importers and grocery chains will face added costs from the 10% tariff on canned vegetable shipments.

Latest Articles

Personalis Executive Activity and Strategic Developments

Personalis Executive Activity and Strategic Developments

Personalis Inc. (NASDAQ: PSNL) has seen significant executive activity and strategic milestones. CFO and COO Aaron Tachibana executed a stock sale under a pre-arranged plan, while the company reported substantial growth in its NeXT Personal minimal residual disease test and expanded Medicare coverage for the diagnostic. These developments occur aga…

Global Graphene Group Disposes of $3.69M Solidion Technology Stake Amid Patent and Financing Developments

Global Graphene Group Disposes of $3.69M Solidion Technology Stake Amid Patent and Financing Developments

Global Graphene Group, Inc., a significant 10% shareholder in Solidion Technology Inc. (NASDAQ:STI), completed a divestment of 175,000 shares on June 4, 2026, totaling $3,691,205. The transaction occurred as Solidion advances its lithium metal battery portfolio with new patent protections and secures bridge financing from its largest shareholder, M…

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Bluejay Diagnostics has closed an $8.5 million private placement priced at-the-market on Nasdaq, with potential to raise an additional $15.2 million through warrant exercises. The proceeds are expected to extend the company's cash runway into Q1 2027, supporting FDA submission and subsequent commercialization of its near-patient sepsis testing prod…

MP Materials CEO Executes $12.8M Stock Sale Amid Valuation Debate

MP Materials CEO Executes $12.8M Stock Sale Amid Valuation Debate

James H. Litinsky, Chairman and CEO of MP Materials Corp. (MP), recently sold 185,167 shares of the company's common stock on June 3, 2026, generating approximately $12.8 million in proceeds. The sales were executed through a weighted average price range of $68.65 to $71.31 per share. Despite the executive's significant divestment, MP Materials rec…

Guardant Health Director Steve Krognes Executes $1.23 Million Stock Sale

Guardant Health Director Steve Krognes Executes $1.23 Million Stock Sale

Guardant Health Inc. (NASDAQ: GH) board member Steve Krognes executed a significant divestment of company shares on June 4, 2026, totaling $1,231,521. The transaction involved the sale of 9,294 shares of common stock, executed at prices ranging from $132.50 to $132.71, with a weighted average sale price of $132.5072. Following this transaction, Kro…

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems

MannKind Corporation announced new clinical and real-world data on Afrezza, its inhaled insulin product, at the ADA 2026 Scientific Sessions. The data build on the recent FDA approval for pediatric use and highlight Afrezza’s safety, efficacy, and patient treatment satisfaction in children, adolescents, and gestational diabetes patients. Additional…

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

Biomea Fusion presented promising clinical and translational data for its oral menin inhibitor icovamenib at the ADA 86th Scientific Sessions, demonstrating benefits in type 1 and type 2 diabetes including improved insulin secretion, glycemic control, muscle preservation, and fat reduction. Additionally, the company announced expansion of its Phase…

Eastern Co Director DiSanto Increases Stake with Recent Share Purchase

Eastern Co Director DiSanto Increases Stake with Recent Share Purchase

Eastern Co (NASDAQ:EML) director Frederick D. DiSanto has acquired an additional 213 shares of the company's common stock, bringing his direct holdings to 101,068 shares. The transaction occurred on June 4, 2026, at a price of $21.50 per share, totaling $4,579. This purchase adds to his existing indirect beneficial ownership through entities linked…

Dillard’s Director J.C. Watts Jr. Executes $243,671 Stock Sale

Dillard’s Director J.C. Watts Jr. Executes $243,671 Stock Sale

Dillard’s, Inc. (NYSE:DDS) director J.C. Watts Jr. executed a significant stock sale, divesting 400 shares of Class A common stock on June 5, 2026. The transaction, valued at $243,671, follows a period of substantial stock appreciation for the retailer. Despite recent robust earnings performance and consistent dividend increases, market analysts co…

Ichor Holdings CEO Executes Pre-Arranged Share Sale Under Rule 10b5-1 Plan

Ichor Holdings CEO Executes Pre-Arranged Share Sale Under Rule 10b5-1 Plan

Philip Ryan Barros Sr., Chief Executive Officer of Ichor Holdings, Ltd. (NASDAQ: ICHR), executed a significant divestment of company stock on June 4, 2026, selling 13,705 ordinary shares for a total of $961,953. The transactions were facilitated through a Rule 10b5-1 trading plan established earlier in the year, with the shares sold at prices rangi…